本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

223.24
-1.8500-0.82%
盘后223.240.00000.00%17:17 EDT
成交量:19.22万
成交额:4,291.43万
市值:44.52亿
市盈率:36.42
高:226.01
开:221.79
低:218.19
收:225.09
52周最高:234.76
52周最低:98.89
股本:1,994.11万
流通股本:1,945.76万
量比:0.61
换手率:0.99%
股息:- -
股息率:- -
每股收益(TTM):6.13
每股收益(LYR):6.13
净资产收益率:13.47%
总资产收益率:2.36%
市净率:4.38
市盈率(LYR):36.42

数据加载中...

2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/01/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

重要事件披露

Current report, item 8.01
2019/12/23

重要事件披露

Current report, item 5.02
2019/11/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/10/16

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/09/12

重要事件披露

Current report, item 8.01
2019/09/12

重要事件披露

Current report, item 8.01
2019/08/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/08

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/06

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/06

持股变动声明

Statement of changes in beneficial ownership of securities